Foreign vaccine suppliers want protection from potential lawsuits against adverse side effects, but analysts say India is in a better position to bargain now that the second wave is receding, domestic supply is rising and new vaccines are hitting the marketPfizer says won’t make exception for India in its global approach for vaccine supply
Foreign vaccine suppliers want protection from potential lawsuits against adverse side effects, but analysts say India is in a better position to bargain now that the second wave is receding, domestic supply is rising and new vaccines are hitting the market
Subscribe to:
Post Comments (Atom)
-
The company, one of the leading manufacturers of soda ash, had initiated the process of carving out its textiles business into GHCL Textile...
-
The BRLLR linked to RBI Repo Rate is revised downwards in line with the reduction on Reserve Bank of India Repo Rate from 5.15 percent to 4...
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
No comments:
Post a Comment